Sinovac Biotech Ltd (SVA) — Capital Reinvestment Ratio
Sinovac Biotech Ltd (SVA) has a Capital Reinvestment Ratio of 0.36x as of December 2023, meaning it reinvests 0% of its operating cash flow ($146.01 Million) in capital expenditures ($52.75 Million). Check Sinovac Biotech Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sinovac Biotech Ltd Capital Reinvestment Ratio (2007–2023)
This chart tracks Sinovac Biotech Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see Sinovac Biotech Ltd (SVA) cash conversion ratio.
Annual Capital Reinvestment Ratio for Sinovac Biotech Ltd (2007–2023)
Year-by-year Capital Reinvestment Ratio for Sinovac Biotech Ltd from 2007 to 2023. See Sinovac Biotech Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.37x | $106.02 Million | $145.69 Million | ▲ +2830.3% |
| 2021 | 0.05x | $15.35 Billion | $719.98 Million | ▼ -82.4% |
| 2020 | 0.27x | $479.31 Million | $127.65 Million | ▼ -2.1% |
| 2019 | 0.27x | $39.07 Million | $10.63 Million | ▼ -61.5% |
| 2018 | 0.71x | $7.94 Million | $5.61 Million | ▲ +254.4% |
| 2017 | 0.20x | $59.76 Million | $11.91 Million | ▼ -84.2% |
| 2015 | 1.26x | $4.21 Million | $5.30 Million | ▲ +36.7% |
| 2013 | 0.92x | $5.58 Million | $5.13 Million | ▼ -17.0% |
| 2011 | 1.11x | $13.94 Million | $15.46 Million | ▲ +1142.9% |
| 2009 | 0.09x | $48.41 Million | $4.32 Million | ▼ -76.4% |
| 2008 | 0.38x | $10.50 Million | $3.98 Million | ▼ -33.8% |
| 2007 | 0.57x | $4.32 Million | $2.47 Million | — |